Loading...
•
Jun 26, 2021
Hologic Q3 2021 Earnings Report
Hologic's financial results for Q3 2021 were announced, with revenue increasing by 42.0% and GAAP diluted EPS reported at $1.04.
Key Takeaways
Hologic reported strong financial results for the third quarter of fiscal year 2021, with revenue increasing 42.0% to $1.168 billion and GAAP diluted EPS reaching $1.04. The company finalized the Mobidiag acquisition and experienced growth in its base businesses.
Revenue increased 42.0% for the quarter, or 37.8% in constant currency.
Organic revenue in the third quarter increased 38.4%, or 34.2% in constant currency, excluding material acquisitions and divestitures.
Worldwide diagnostics revenue increased 25.0%, despite lower demand for COVID assays.
The company completed the acquisition of Mobidiag for approximately $808 million.
Hologic
Hologic
Hologic Revenue by Segment
Hologic Revenue by Geographic Location
Revenue by Segment
Diagnostics Revenue
CapyFin.comMolecular Diagnostics Revenue
CapyFin.comBlood Screening Revenue
CapyFin.comBreast Health Revenue
CapyFin.comBreast Imaging Revenue
CapyFin.comInterventional Breast Solutions Revenue
CapyFin.comGYN Surgical Revenue
CapyFin.comSkeletal Health Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
For Q4 2021, Hologic anticipates strong growth in base businesses, which will be offset by declines in COVID testing revenue.
Revenue & Expenses
Visualization of income flow from segment revenue to net income